Activation of Raphe Efferents to the Medial Prefrontal Cortex by Corticotropin-Releasing Factor: Correlation with Anxiety-Like Behavior

Biological Psychiatry

Volumn 63, Issue 9, 2008, Pages 832-839

  Meloni, Edward G ^a   Reedy, Catherine L ^a   Cohen, Bruce M ^a   Carlezon Jr , William A ^a  

^a MCLEAN HOSPITAL   (United States)

Author keywords

c Fos; prefrontal cortex; raphe; serotonin; startle; stress

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; PROTEIN C FOS; SEROTONIN; TRYPTOPHAN HYDROXYLASE;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DEPRESSION; IMMUNOHISTOCHEMISTRY; MALE; MEDIAN RAPHE NUCLEUS; NEUROANATOMY; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SEROTONINERGIC NERVE CELL; SEROTONINERGIC SYSTEM; STARTLE REFLEX; STATISTICAL ANALYSIS;

AFFECT; ANIMALS; ANXIETY DISORDERS; AROUSAL; BRAIN MAPPING; CORTICOTROPIN-RELEASING HORMONE; EFFERENT PATHWAYS; MALE; NEURONS; PREFRONTAL CORTEX; PROTO-ONCOGENE PROTEINS C-FOS; RAPHE NUCLEI; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; STARTLE REACTION;

EID: 41449096422     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2007.10.016     Document Type: Article

References (68)

1. Owens M.J., and Nemeroff C.B. The role of corticotropin-releasing factor in the pathophysiology of affective and anxiety disorders: Laboratory and clinical studies. Ciba Found Symp 172 (1993) 296-308
2. Heim C., and Nemeroff C.B. The role of childhood trauma in the neurobiology of mood and anxiety disorders: Preclinical and clinical studies. Biol Psychiatry 49 (2001) 1023-1039
3. Boyer P. Do anxiety and depression have a common pathophysiological mechanism?. Acta Psychiatr Scanf 102 (2000) 24-29
4. Bakshi V.P., and Kalin N.H. Corticotropin-releasing hormone and animal models of anxiety: Gene-environment interactions. Biol Psychiatry 48 (2000) 1175-1198
5. Steckler T., and Holsboer F. Corticotropin-releasing hormone receptor subtypes and emotion. Biol Psychiatry 46 (1999) 1480-1508
6. 2 receptors in fear and anxiety. Neurosci Biobehav Rev 25 (2001) 627-636
7. Weiss J.M., Stout J.C., Aaron M.F., Quan N., Owens M.J., Butler P.D., et al. Depression and anxiety: role of the locus coeruleus and corticotropin-releasing factor. Brain Res Bull 35 (1994) 561-572
8. Koob G.F. Corticotropin-releasing factor, norepinephrine, and stress. Biol Psychiatry 46 (1999) 1167-1180
9. Ströhle A., and Holsboer F. Stress responsive neurohormones in depression and anxiety. Pharmacopsychiatry 36 suppl 3 (2003) S207-S214
10. Mitchell A.J. The role of corticotropin releasing factor in depressive illness: a critical review. Neurosci Biobehav Rev 22 (1998) 635-651
11. Arborelius L., Owens M.J., Plotsky P.M., and Nemeroff C.B. The role of corticotropin-releasing factor in depression and anxiety disorders. J Endocrinol 160 (1999) 1-12
12. Ressler K.J., and Nemeroff C.B. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety 12 (2000) 2-19
13. Lowry C.A., and Moore F.L. Regulation of behavioral responses by corticotropin-releasing factor. Gen Comp Endocrinol 146 (2006) 19-27
14. Linthorst A.C. Interactions between corticotropin-releasing hormone and serotonin: Implications for the aetiology and treatment of anxiety disorders. Handb Exp Pharmacol 169 (2005) 181-204
15. Ruggiero D.A., Underwood M.D., Rice P.M., Mann J.J., and Arango V. Corticotropin-releasing hormone and serotonin interact in the human brainstem: Behavioral implications. Neuroscience 4 (1999) 1343-1354
16. Austin M.C., Janosky J.E., and Murphy H.A. Increased corticotropin-releasing hormone immunoreactivity in monoamine-containing pontine nuclei of depressed suicide men. Mol Psychiatry 8 (2003) 324-332
17. Lowry C.A., Rodda J.E., Lightman S.L., and Ingram C.D. Corticotropin-releasing factor increases in vitro firing rates of serotonergic neurons in the rat dorsal raphe nucleus: Evidence for activation of a topographically organized mesolimbic serotonergic system. J Neurosci 20 (2000) 7728-7736
18. Pernar L., Curtis A.L., Vale W.W., Rivier J.E., and Valentino R.J. Selective activation of corticotropin-releasing factor-2 receptors on neurochemically identified neurons in the rat dorsal raphe nucleus reveals dual action. J Neurosci 24 (2004) 1305-1311
19. Kirby L.G., Rice K.C., and Valentino R.J. Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus. Neuropsychopharmacology 22 (2000) 148-162
20. de Groote L., Penalva R.G., Flachskamm C., Reul J.M.H.M., and Linthorst A.C.E. Differential monoaminergic, neuroendocrine and behavioural responses after central administration of corticotropin-releasing factor receptor type 1 and type 2 agonists. J Neurochem 94 (2005) 45-56
21. Kagamiishi Y., Yamamoto T., and Watanabe S. Hippocampal serotonergic system is involved in anxiety-like behavior induced by corticotropin-releasing factor. Brain Res 991 (2003) 212-221
22. Price M.L., and Lucki I. Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor. J Neurosci 21 (2001) 2833-2841
23. Dunn A.J., and Berridge C.W. Corticotropin-releasing factor administration elicits a stress-like activation of cerebral catecholaminergic systems. Pharmacol Biochem Behav 27 (1987) 685-691
24. Drevets W.C., Price J.L., Simpson J.R., Todd R.D., Reich T., Vannier M., et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386 (1997) 824-827
25. Shin L.M., Rauch S.L., and Pitman R.K. Amygdala, medial prefrontal cortex, and hippocampal function in PTSD. Ann N Y Acad Sci 1071 (2006) 67-79
26. Vertes R.P. a PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat. J Comp Neurol 313 (1991) 643-668
27. Forster G.L., Feng N., Watt M.J., Korzan W.J., Mouw N.J., Summers C.H., et al. Corticotropin-releasing factor in the dorsal raphe elicits temporally distinct serotonergic responses in the limbic system in relation to fear behavior. Neuroscience 141 (2006) 1047-1055
28. Lavicky J., and Dunn A.J. Corticotropin-releasing factor stimulates catecholamine release in hypothalamus and prefrontal cortex in freely moving rats as assessed by microdialysis. J Neurochem 60 (1993) 602-612
29. Lee Y., and Davis M. Role of the hippocampus, bed nucleus of the stria terminalis and amygdala in the excitatory effect of corticotropin releasing hormone (CRH) on the acoustic startle reflex. J Neurosci 17 (1997) 6434-6446
30. Meloni E.G., Gerety L.P., Knoll A.T., Cohen B.M., and Carlezon W.A. Behavioral and anatomical interactions between dopamine and corticotropin-releasing factor in the rat. J Neurosci 26 (2006) 3855-3863
31. Hoffman G.E., Smith M.S., and Verbalis J.G. c-Fos and related immediate early gene products as markers of activity in neuroendocrine systems. Front Neuroendocrinol 14 (1993) 173-213
32. Hoffman G.E., and Lyo D. Anatomical markers of activity in neuroendocrine systems: Are we all 'Fos-ed out'?. J Neuroendocrinol 14 (2002) 259-268
33. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. 3rd ed. (1997), Academic Press, New York
34. Abrams J.K., Johnson P.L., Hollis J.H., and Lowry C.A. Anatomic and functional topography of the dorsal raphe nucleus. Ann N Y Acad Sci 1018 (2004) 46-57
35. Kovacs K.J. c-Fos as a transcription factor: A stressful (re)view from a functional map. Neurochem Int 33 (1998) 287-297
36. Mikkelsen J.D., Hay-Schmidt A., and Larsen P.J. Central innervation of the rat ependyma and subcommissural organ with special reference to ascending serotoninergic projections from the raphe nuclei. J Comp Neurol 384 (1997) 556-568
37. Simpson K.L., Fisher T.M., Waterhouse B.D., and Lin R.C.S. Projection patterns from the raphe nuclear complex to the ependymal wall of the ventricular system in the rat. J Comp Neurol 399 (1998) 61-72
38. Lowry C.A., Johnson P.L., Hay-Schmidt A., Mikkelsen J., and Shekhar A. Modulation of anxiety circuits by serotonergic systems. Stress 8 (2005) 233-246
39. Valentino R.J., Liouterman L., and Van Bockstaele E.J. Evidence for regional heterogeneity in corticotropin-releasing factor interactions in the dorsal raphe. J Comp Neurol 435 (2001) 450-463
40. Waselus M., Valentino R.J., and Van Bockstaele E.J. Ultrastructural evidence for a role of γ-aminobutyric acid in mediating the effects of corticotropin-releasing factor on the rat dorsal raphe serotonin system. J Comp Neurol 482 (2005) 155-165
41. DeSouza E.B., Insel T.R., Perrin M.H., Rivier J., Vale W.W., and Kuhar M.J. Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: An autoradiographic study. J Neurosci 5 (1985) 3189-3203
42. Day H.E.W., Greenwood B.N., Hammack S.E., Watkins L.R., Fleshner M., Maier S.F., et al. Differential expression of 5-HT-1A, a1b adrenergic, CRF-R1, and CRF-R2 receptor mRNA in serotonergic, γ-aminobutyric acidergic, and catecholaminergic cells of the rat dorsal raphe nucleus. J Comp Neurol 474 (2004) 364-378
43. Van Pett K., Viau V., Bittencourt J.C., Chan R.K.W., Li H.-Y., Arias C., et al. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 428 (2000) 191-212
44. Reyes T.M., Lewis M.H., Perrin M.H., Kunitake K.S., Vaughan J., Arias C.A., et al. Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci U S A 98 (2001) 2843-2848
45. Lewis K., Li C., Perrin M.H., Blount A., Kunitake K., Donaldson C., et al. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci U S A 98 (2001) 7570-7575
46. Amat J., Tamblyn J.P., Paul E.D., Bland S.T., Amat P., Foster A.C., et al. Microinjections of urocortin 2 into the dorsal raphe nucleus activates serotonergic neurons and increases extracellular serotonin in the basolateral amygdala. Neuroscience 129 (2004) 509-519
47. Staub D.R., Evans A.K., and Lowry C.A. Evidence supporting a role for corticotropin-releasing factor type 2 (CRF2) receptors in the regulation of subpopulations of serotonergic neurons. Brain Res 1070 (2006) 77-89
48. Risbrough V.B., Hauger R.L., Pelleymounter M.A., and Geyer M.A. Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice. Psychopharmacology 170 (2003) 178-187
49. Liang K.C., Melia K.R., Miserendino M.J.D., Falls W.A., Campeau S., and Davis M. Corticotropin-releasing factor: Long-lasting facilitation of the acoustic startle reflex. J Neurosci 12 (1992) 2303-2312
50. Hajos M., Gartside S.E., Varga V., and Sharp T. In vivo inhibition of neuronal activity in the rat ventromedial prefrontal cortex by midbrain-raphe nuclei: Role of 5-HT1A receptors. Neuropharmacology 45 (2003) 72-81
51. Puig M.V., Artigas F., and Celada P. Modulation of the activity of pyramidal neurons in the rat prefrontal cortex by raphe stimulation in vivo: Involvement of serotonin and GABA. Cereb Cortex 15 (2005) 1-14
52. Mantz J., Godbout R., Tassin J.-P., Glowinski J., and Thierry A.-M. Inhibition of spontaneous and evoked unit activity in the rat medial prefrontal cortex by mesencephalic raphe nuclei. Brain Res 524 (1990) 22-30
53. Zhou F.-M., and Hablitz J.J. Activation of serotonin receptors modulates synaptic transmission in rat cerebral cortex. J Neurophysiol 82 (1999) 2989-2999
54. Tan H., Zhong P., and Yan Z. Corticotropin-releasing factor and acute stress prolongs serotonergic regulation of GABA transmission in prefrontal cortical pyramidal neurons. J Neurosci 24 (2004) 5000-5008
55. Ashby C.R., Edwards E., and Wang R.Y. Action of serotonin in the medial prefrontal cortex: Mediation by serotonin2-like receptors. Synapse 10 (1992) 7-15
56. Aghajanian G.K., and Marek G.J. Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells. Neuropharmacology 36 (1997) 589-599
57. Yan Z. Regulation of GABAergic inhibition by serotonin signaling in prefrontal cortex. Mol Neurobiol 26 (2002) 1-14
58. Puig M.V., Santana N., Celada P., Mengod G., and Artigas F. In vivo excitation of GABA interneurons in the medial prefrontal cortex through 5-HT3 receptors. Cereb Cortex 14 (2004) 1365-1375
59. Santana N., Bortolozzi A., Serrats J., Mengod G., and Artigas F. Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. Cereb Cortex 14 (2004) 1100-1109
60. Amat J., Baratta M.V., Paul E., Bland S.T., Watkins L.R., and Maier S.F. Medial prefrontal cortex determines how stressor controllability affects behavior and dorsal raphe nucleus. Nat Neurosci 8 (2005) 365-371
61. Deakin J.W.F., and Graeff F.G. 5-HT and mechanisms of defence. J Psychopharmacol 5 (1991) 305-315
62. Sierra-Mercado D.J., Corcoran K.A., Lebron-Milad K., and Quirk G.J. Inactivation of the ventromedial prefrontal cortex reduces expression of conditioned fear and impairs subsequent recall of extinction. Eur J Neurosci 24 (2006) 1751-1758
63. Rauch S.L., Shin L.M., Whalen P.J., and Pitman R.K. Neuroimaging and the neuroanatomy of PTSD. CNS Spectrums 3 suppl 2 (1998) 30-41
64. Kasckow J.W., Baker D., and Geracioti Jr. T.D. Corticotropin-releasing hormone in depression and post-traumatic stress disorder. Peptides 22 (2001) 845-851
65. Baker D.G., West S.A., Nicholson W.E., Ekhator N.N., Kasckow J.W., Hill K.K., et al. Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder. Am J Psychiatry 156 (1999) 585-588
66. Vertes R.P. Differential projections of the infralimbic and prelimbic cortex in the rat. Synapse 51 (2004) 32-58
67. Walker D.L., Toufexis D.J., and Davis M. Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety. Eur J Neurosci 463 (2003) 199-216
68. Meloni E.G., and Davis M. Synergistic enhancement of the acoustic startle reflex by dopamine D1 and 5-HT1A agonists and corresponding changes in c-Fos expression in the dorsal raphe of rats. Psychopharmacology 151 (2000) 359-367